Get AxoGen alerts:AxoGen, Inc. (NASDAQ:AXGN – Free Report) – Analysts at HC Wainwright issued their Q3 2025 earnings estimates for AxoGen in a research note issued to investors on Tuesday, September 30th. HC Wainwright also issued estimates for AxoGen’s Q4 2025 earnings at ($0.01) EPS, FY2025 earnings at ($0.09) EPS, Q1 2026 earnings at $0.00 EPS, Q2 2026 earnings at $0.02 EPS, Q3 2026 earnings at $0.05 EPS, Q4 2026 earnings at $0.07 EPS and FY2026 earnings at $0.14 EPS. Weiss Ratings reiterated a “sell (d-)” rating on shares of AxoGen in a report on Saturday, September 27th. Balyasny Asset Management L.P. boosted its holdings in AxoGen by 183.9% during the second quarter. Soleus Capital Management L.P. lifted its stake in AxoGen by 0.9% in the second quarter.